These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 3763088

  • 1. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP, Stehman FB, Michael H, Young PC, Ehrlich CE.
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [Abstract] [Full Text] [Related]

  • 2. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
    Liao BS, Twiggs LB, Leung BS, Yu WC, Potish RA, Prem KA.
    Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
    [Abstract] [Full Text] [Related]

  • 3. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ, Isotalo HE, Kivinen ST, Vihko RK.
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS, Barton TK, Fetter BF, Creasman WT, McCarty KS.
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [Abstract] [Full Text] [Related]

  • 8. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.
    J Natl Cancer Inst; 2005 Sep 07; 97(17):1254-61. PubMed ID: 16145046
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
    Friedl A, Gottardis MM, Pink J, Buchler DA, Jordan VC.
    Cancer Res; 1989 Sep 01; 49(17):4758-64. PubMed ID: 2758409
    [Abstract] [Full Text] [Related]

  • 12. Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas.
    Soper JT, McCarty KS, Hinshaw W, Creasman WT, McCarty KS, Clarke-Pearson DL.
    Am J Obstet Gynecol; 1984 Oct 15; 150(4):342-8. PubMed ID: 6486200
    [Abstract] [Full Text] [Related]

  • 13. Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters.
    Kitaoka Y, Kitawaki J, Koshiba H, Inoue S, Ishihara H, Teramoto M, Honjo H.
    J Steroid Biochem Mol Biol; 2004 Feb 15; 88(2):183-9. PubMed ID: 15084350
    [Abstract] [Full Text] [Related]

  • 14. Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles.
    Ioffe YJ, Li AJ, Walsh CS, Karlan BY, Leuchter R, Forscher C, Cass I.
    Gynecol Oncol; 2009 Dec 15; 115(3):466-71. PubMed ID: 19767065
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
    Rose PG, Reale FR, Longcope C, Hunter RE.
    Obstet Gynecol; 1990 Aug 15; 76(2):258-63. PubMed ID: 2371031
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.